MSD (Merck & Co) has won US Food and Drug Administration (FDA) approval for its cholesterol-lowering pill, marking a significant milestone in the drugmaker’s push to reduce revenue reliance on ...

The FDA has issued traditional approval to Novartis for Fabhalta to slow the decline of kidney function in adults with primary IgAN who are at risk of disease progression.

Blood-based biomarkers could play a key role in detecting and treating Alzheimer’s early at the first point of contact, experts say.

Harbour BioMed and Kelun-Biotech have received approval from China’s NMPA for their IND application for the HBM7575/SKB575 bispecific antibody intended to treat asthma.

Bayer's Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.

The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended a routine programme with the 4CMenB vaccine for adolescents.

Novo Nordisk is continuing to maintain its advantage in the obesity pill race after winning European approval for oral Wegovy (semaglutide). The European Commission (EC) granted m ...

There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.

Telix Pharmaceuticals has opened a radiopharmaceutical facility in Melbourne, Australia, to expedite the delivery of new cancer treatments.

Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus to treat multiple sclerosis.

Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle platform.

The pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreement ...